PURPL has been shown to deplete P53 levels in colorectal cancer cells through its interaction with the Myb-binding protein 1A (MYBBP1A), a protein that binds to and stabilizes p53, and PURPL-deficient cells exhibit impaired tumor growth [71]. Here, PURPL is linked to colorectal cancer.